4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-077259
Chief Scientific Officer sold 1,780 shares at $14.14 ($25,169)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-25 | Sale : show line 1 in the form 10b5-1 | −1,780 | $14.14 | $25,169 | 174,844 | D |
| Open-market sales · 1,780 sh · avg $14.14 · $25,169 | ||||||
Loading xslF345X05/ownership.xml…